Cell therapy using cardiosphere-derived cells (CDCs) is
an increasingly promising treatment for acute and congenital heart muscle
injuries, including myocardial infarction (MI). The the
A group of researchers from the Institute of Health Carlos III (ISCIII) in Spain, presented a poster at the annual meeting for the International Society of Extracellular Vesicles (ISEV), which analyze
